Noclog 75 mg (Tablet)
Unit Price: ৳ 12.00 (4 x 10: ৳ 480.00)
Strip Price: ৳ 120.00
Medicine Details
Category | Details |
---|---|
Generic | Clopidogrel bisulphate |
Company | Eskayef pharmaceuticals ltd |
Title and Categories
- Noclog Anti-Platelet Medication
- Therapeutic Class: Anti-platelet drugs
Indications
- Reduces the rate of myocardial infarction (MI)
- Reduces the rate of stroke
- Indicated for Acute Coronary Syndrome (ACS)
- Indicated for non-ST-segment elevation ACS
- Indicated for unstable angina (UA)
- Indicated for non-ST-elevation myocardial infarction (NSTEMI)
- Indicated for acute ST-elevation myocardial infarction (STEMI)
- Indicated for Recent MI, Recent Stroke, or Established Peripheral Arterial Disease
- Reduces the rate of MI in patients with established peripheral arterial disease
- Reduces the rate of stroke in patients with established peripheral arterial disease
Pharmacology
- Clopidogrel is a prodrug
- Inhibits platelet activation
- Inhibits platelet aggregation
- Irreversibly binds to the P2Y12 class of ADP receptors on platelets
- Dose-dependent inhibition of platelet aggregation
- Inhibition of platelet aggregation can be seen 2 hours after single oral doses
Dosage & Administration
- 300 mg oral loading dose for patients who need an antiplatelet effect within hours
- 75 mg once daily orally for Recent MI, Recent Stroke, or Established Peripheral Arterial Disease
- Initiating without a loading dose will delay establishment of an antiplatelet effect
- Can be given orally with or without food
Interactions
- Increases risk of bleeding with NSAIDs, warfarin, selective serotonin and serotonin norepinephrine reuptake inhibitors (SSRIs, SNRIs)
- Avoid concomitant use with CYP2C19 inhibitors (omeprazole or esomeprazole)
- Increases plasma concentrations of Repaglinide when used concomitantly with Repaglinide
Contraindications
- Hypersensitivity to the drug substance
- Hypersensitivity to any component of the product
- Active pathological bleeding such as peptic ulcer or intracranial hemorrhage
Side Effects
- Common: Bleeding, Diarrhoea, gastrointestinal discomfort, haemorrhage, Skin reactions
- Rare: Acquired haemophilia, anaemia, angioedema, arthralgia, arthritis, bone marrow disorders
Pregnancy & Lactation
- Should be used during pregnancy only if clearly needed
- Unknown whether clopidogrel is excreted in human breast milk
- Decision should be made on whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother
Precautions & Warnings
- Metabolism to active metabolite impaired by genetic variations in CYP2C19
- Metabolism to active metabolite impaired by drugs that inhibit CYP2C19
- Inhibition of platelet aggregation for the lifetime of the platelet
- Increased risk of bleeding
- Discontinuation increases the risk of cardiovascular events
- Risk of Thrombotic Thrombocytopenic Purpura (TTP)
- Risk of hypersensitivity including rash, angioedema, or hematologic reaction
- Thrombotic Thrombocytopenic Purpura (TTP) reported
Use in Special Populations
- Safety and effectiveness in pediatric populations not established
- No dosage adjustment necessary in elderly patients
Overdose Effects
- May lead to bleeding complications
- Platelet transfusion may restore clotting ability
Storage Conditions
- Keep below 30°C temperature
- Store in a dry place
- Protected from light
- Do not freeze
- Keep out of the reach of children